Total | Group A | Group B | P-value | |
---|---|---|---|---|
Age | 61 ± 13 | 64 ± 12 | 59 ± 12 | 0.14 |
Male | 73 (72%) | 18 (74%) | 55 (71%) | 0.63 |
BPs (mmHg) | 130 ± 19 | 137 ± 23 | 128 ± 17 | 0.04 |
BPd (mmHg) | 77 ± 10 | 79 ± 10 | 76 ± 10 | 0.14 |
Height (m) | 1.62 ± 0.09 | 1.60 ± 0.08 | 1.63 ± 0.09 | 0.12 |
Weight (kg) | 61.8 ± 11.1 | 61.9 ± 9.6 | 61.7 ± 11.8 | 0.94 |
BSA (m2 ) | 1.67 ± 0.18 | 1.65 ± 0.16 | 1.67 ± 0.19 | 0.75 |
History of HT | 43 (42%) | 16 (67%) | 27 (35%) | <0.0001 |
DM | 10 (10%) | 3 (13%) | 7 (9%) | 0.37 |
HL | 49 (48%) | 12 (50%) | 37 (47%) | 0.67 |
PAF | 23 (23%) | 13 (54%) | 10 (13%) | <0.0001 |
Medications Aspirin | 15 (15%) | 8 (33%) | 7 (9%) | <0.0001 |
Warfarin | 4 (17%) | 4 (17%) | 0 | <0.001 |
Calcium ant. | 41 (40%) | 11 (46%) | 30 (38%) | 0.25 |
Beta-blockers | 44 (43%) | 11 (46%) | 33 (42%) | 0.57 |
Diuretics | 6 (6%) | 3 (13%) | 3 (4%) | 0.02 |
ACE inhibitor | 19 (19%) | 8 (33%) | 11 (14%) | 0.002 |